Nutreco, BiomEdit to transform feed additives through microbiome technology

332

Nutreco and BiomEdit have announced their long-term research and commercial partnership to bring livestock producers novel feed additives developed through microbiome technology.

The collaboration covers the discovery, development, and commercialization of biome-actives developed using BiomEdit’s microbiome science and bioinformatics platform. These novel feed additives address the health and sustainability challenges of today’s animal producers, for poultry, swine, cattle, and aquaculture.

Read more about microbiome:
Elanco, Ginkgo Bioworks leverage microbiome technology
Cargill introduces innovation to determine gut microbiome health
Core metagenomic functions of the poultry microbiome

From left, David Bravo, Julie Lawless, President of Lawless Strategic Communications, and Aaron Schacht.

In recent years, studies into the gut microbiome have led to a basic understanding of their role in human and animal health and in how foods are digested in the gastrointestinal tract. Influencing the gut microbiome – the microbes – what they produce and their environment, for example through food supplements or medicines, can have a major impact on human health – and, similarly, can impact the health, well-being, and performance of animals. 

“Instead of focusing on microbiome composition and how to affect it, at Nutreco, we believe that mining the microbiome to find microbial functions that will benefit the animal’s physiology will unlock real sustainable progress for the welfare, health, and productivity of farm animals,” said Nutreco’s Chief Science Officer David Bravo.

Aaron Schacht, CEO of BiomEdit, said: “Microbiome science has the potential to address the complex health challenges and unmet needs our customers and their livestock face today. By leveraging BiomEdit’s microbiome discovery platform and bench of experts together with Nutreco’s expertise and commercial deployment capabilities, we will launch novel feed additives that address some of the most important problems in animal health, sustainability, and food security.”

BiomEdit, established in April 2022 in a carve out from Elanco Animal Health, is a venture-backed startup focused on the discovery and development of animal health products that leverage microbiome science to improve animal health, animal protein production, and livestock disease monitoring. This is its first commercial partnership since it began with contributions of assets and technology from Elanco and Ginkgo Bioworks.